BRAF and neoplasm: Patient triage could be performed by a quick assessment of tumor burden and testing of biomarkers with predictive and prognostic value (such as immunohistochemistry for mismatch repair proteins; sequence variation analysis for KRAS [GenBank 3845], NRAS [GenBank 4893], and BRAF).